Coya Therapeutics (COYA) Share-based Compensation (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Share-based Compensation data on file, last reported at $7.3 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 575.87% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (up 120.68% YoY), and the FY2025 full-year result was $5.1 million, down 5.56% from the prior year.
• Share-based Compensation improved to $7.3 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $7.3 million in Q1 2026 to a low of $21425.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $435663.0 in 2024 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 971.99% in 2025, while the deepest fall reached 39.6% in 2025.
• Tracing COYA's Share-based Compensation over 5 years: stood at $71429.0 in 2022, then soared by 233.2% to $237999.0 in 2023, then jumped by 232.16% to $790549.0 in 2024, then jumped by 39.6% to $1.1 million in 2025, then soared by 561.45% to $7.3 million in 2026.
• Business Quant data shows COYA's Share-based Compensation at $7.3 million in Q1 2026, $1.1 million in Q4 2025, and $6.4 million in Q3 2025.